Product ID |
Product Name |
CAS# |
Purity |
Y3289470 |
CDK8-IN-3 |
1884500-15-5 |
99% |
Y3162659 |
RORt Inverse agonist 10 |
2413986-35-1 |
99% |
Y3167632 |
Methyl carnosate |
82684-06-8 |
98% |
Y3309819 |
FFN270 hydrochloride |
2341841-05-0 |
99.0% |
Y3167881 |
JTT 551 |
776309-04-7 |
99% |
Y3304878 |
5-Methyl-4-phenyl-2-(trifluoromethylphenyl)-thiazole |
1858251-30-5 |
97% |
Y3306998 |
N-[1-(hydroxyamino)isoquinolin-3-yl]hydroxylamine |
1823607-75-5 |
97% |
Y3308802 |
2-Ferrocenyl-6-methylbenzimidazole |
101408-74-6 |
97% |
Y3317235 |
2-NITRO-4-(TRIFLUOROMETHOXY)BENZALDEHYDE |
1214385-94-0 |
98% |
Y3296976 |
Bis-PEG12-acid |
2667583-09-5 |
95% |
Y3305654 |
Biotin-PEG3-SS-azide |
2866429-93-6 |
99% |
Y3169544 |
Macropa-NH2 TFA |
2705054-08-4 |
96% |
Y3290344 |
3-(2-pyridinyl)-1H-pyrazole-5-carboxylic acid |
1106669-60-6 |
95% |
Y3306169 |
2-Bromo-1-methoxy-4-(2,2,2-trifluoroethyl)benzene |
1897696-92-2 |
90% |
Y3310814 |
1-Chloro-2-(1-trifluoromethyl-cyclopropyl)-benzene |
1936216-87-3 |
97% |
Y3311018 |
4-Methyl-5-trifluoromethyl-2-(4-bromo-phenyl)-thiazole |
1896266-23-1 |
90% |
Y3306543 |
1,3-Diphenylimidazolidine |
2513-64-6 |
98% |
Y3309092 |
4-Methyl-5-trifluoromethyl-2-(3-fluoro-phenyl)-thiazole |
1896266-24-2 |
98% |
Y3309130 |
3-(Hexadecylsulfanyl)benzoic acid |
198972-06-4 |
90% |
Y3305553 |
2,6-Bis[(ethoxycarbonyl)amino]pyridin-1-ium-1-olate |
84043-86-7 |
tech |
Y3304970 |
(1E)-4,4-Dimethyl-1-phenylpent-1-en-3-one |
29569-91-3 |
96% |
Y3306118 |
11,12-Dimethyl-4-thia-2,7,11,13-tetraazatricyclo[7.4.0.0³,7]trideca-1(9),2,5,10,12-pentaen-11-ium perchlorate |
86046-07-3 |
tech |
Y3311748 |
(E,E)-Bis[(4-methylphenyl)methylidene]hydrazine |
139030-29-8 |
98% |
Y3306087 |
Ethyl (2Z)-2-cyano-3-[(methylcarbamoyl)amino]prop-2-enoate |
162129-66-0 |
97% |
Y3308948 |
2,4,4-Trimethylpentyl 2-(5-{2-oxo-2-[(2,4,4-trimethylpentyl)oxy]ethyl}-1,3-dioxan-5-yl)acetate |
304690-36-6 |
95% |
Y3309684 |
1-(4-Methoxyphenyl)-2,4,6-triphenylpyridinium perchlorate |
25506-72-3 |
96% |
Y3308827 |
2-Benzenesulfonamidopyridin-1-ium-1-olate |
72805-13-1 |
98% |
Y3307893 |
3-(2-Methylphenyl)-1,2-diphenyl-1H-pyrrole |
197172-47-7 |
98% |
Y3309495 |
1,2-Dimethyl 3,3-dimethyl-7-oxo-3H,5H,6H,7H-pyrazolo[1,2-a]pyrazolidine-1,2-dicarboxylate |
19948-51-7 |
98% |
Y3304831 |
1,2-Dimethyl 7-oxo-3-phenyl-3H,5H,6H,7H-pyrazolo[1,2-a]pyrazolidine-1,2-dicarboxylate |
166879-76-1 |
98% |
Y3168005 |
3-chloro-2-methylphenylacetic acid |
35703-39-0 |
95% |
Y3162672 |
3-chloro-2-methylphenylacetonitrile |
35703-53-8 |
95% |
Y3316956 |
3-bromo-5-(difluoromethoxy)anisole |
1261446-31-4 |
97% |
Y3160608 |
3-iodomandelic acid |
873963-87-2 |
95% |
Y3311292 |
3-Amino-1H-pyrazole-4-carboxamidoxime |
41621-12-9 |
97% |
Y3310490 |
1,3-Bis(4-ethoxycarbonylmethyl-2-thiazolyl)benzene |
1858256-06-0 |
98% |
Y3310841 |
2-Phenyl-3-methylimidazo[1,2-b]thiazole |
1823495-94-8 |
97% |
Y3305414 |
5-Benzoyl-2-(3-cyanophenyl)benzimidazole |
1858251-00-9 |
97% |
Y3111629 |
4-(tert-Butyl)-2-[4-(tert-butyl)phenyl]pyridine, 95% |
808142-68-9 |
98% |
Y3160754 |
6-Pentafluoroethyl-2-pyridinecarboxylic acid, 95% |
1283717-85-0 |
95% |
Y3165945 |
3-Pentyloctanoic acid |
1397196-39-2 |
95% |
Y3287801 |
L-Serine-15N-N-FMOC |
2137490-19-6 |
98% |
Y3294669 |
(Aminomethyl-d2)phosphonic Acid |
30926-24-0 |
99% |
Y3292339 |
Tetracosanoic-21,21,22,22,23,23,24,24,24-d9 Acid |
2415226-90-1 |
98% |
Y3287954 |
Isoxsuprine-d6 HCl (3-phenoxy-2-propyl-1,1,1,2,3,3-d6-amine)(mixture of diastereomers) |
2706004-35-3 |
95% |
Y3164111 |
Indole-3-propionic-2,2-d2 Acid |
2469257-98-3 |
99% |
Y3286308 |
Lamotrigine-d3 (2,3-dichlorophenyl-d3) |
1132746-94-1 |
95% |
Y3293451 |
N-Suberyl-2,2,7,7-d4-glycine |
2469259-73-0 |
99% |
Y3165947 |
D-Alanine-d7 |
2483831-62-3 |
99.0% |
Y3309404 |
4-Androsten-11ß-ol-3,17-dione-2,2,4,6,6,16,16-d7 |
2331287-27-3 |
99% |
Y3162492 |
2,5-dihydro-2-methyl-5-oxo-1H-Pyrrole-1-carboxylic acid 1,1-dimethylethyl ester |
128372-91-8 |
95% |
Y3165959 |
6,7-dihydro-3-(hydroxymethyl)-4(5H)-Benzofuranone |
148587-51-3 |
95% |
Y3169557 |
3-methyl-4-Benzofuranol |
3610-15-9 |
95% |
Y3170415 |
2-Furanpropanal |
4543-51-5 |
95% |
Y3158997 |
4-(fluoromethyl)-2(5H)-Furanone |
916069-77-7 |
95% |
Y3158311 |
2,2-dimethyl-5-oxo-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester |
1269773-66-1 |
95% |
Y3152145 |
2,3,6,7,8,12b-hexahydro-Pyrazino[2,1-a][2]benzazepin-4(1H)-one |
98123-61-6 |
95% |
Y3158312 |
(R)-1-(4-methylpiperazin-1-yl)propan-2-amine |
1161872-92-9 |
95% |
Y3159062 |
3-methyl-1-Isoquinolinamine |
155999-48-7 |
95% |
Y3159008 |
4-chloro-3-(difluoromethyl)-Pyridine |
947371-37-1 |
95% |
Y3155046 |
2,6-Pyridinediacetonitrile |
46133-38-4 |
95% |
Y3155383 |
6-chloro-5-ethyl-2-Pyridinamine |
1004294-54-5 |
95% |
Y3155218 |
4-chloro-3-Pyridineacetonitrile |
142892-30-6 |
95% |
Y3160923 |
5,6,7,8-tetrahydro-5-methyl-1,6-Naphthyridine |
83081-95-2 |
95% |
Y3167835 |
5,6,7,8-tetrahydro-7-methyl-1,6-Naphthyridine |
83082-05-7 |
95% |
Y3170148 |
2-fluoro-4,6-dimethyl-3-Pyridinecarbonitrile |
1179487-78-5 |
95% |
Y3170149 |
2-cyano-1-methyl-Pyridinium iodide |
3785-03-3 |
95% |
Y3163675 |
2-amino-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4(3H)-one dihydrochloride |
2648941-90-4 |
95% |
Y3164342 |
N-(1,6-dihydro-4-methyl-6-oxo-2-pyrimidinyl)-1H-Imidazole-1-carboxamide |
561316-60-7 |
95% |
Y3163575 |
5-bromo-2-ethoxy-1H-Imidazole-4-carboxaldehyde |
1073549-03-7 |
95% |
Y3129094 |
1-(2,6-dimethylphenyl)-1,3-dihydro-2H-Imidazole-2-thione |
17452-19-6 |
95% |
Y3168929 |
NK1 receptor antagonist 2 |
579475-17-5 |
97.98% |
Y3170417 |
(Rac)-Etavopivat |
2622070-93-1 |
99% |
Y3164119 |
Thalidomide-PEG5-NH2 hydrochloride |
2703775-06-6 |
94% |
Y3169455 |
PAD-IN-2 |
2304852-21-7 |
99% |
Y3162497 |
PI3K/mTOR Inhibitor-4 |
2361215-32-7 |
97.00% |
Y3297039 |
LKY-047 |
1954681-29-8 |
98% |
Y3111668 |
CMC2.24 |
1255639-43-0 |
98% |
Y3291233 |
TTT-28 |
1609138-51-3 |
99% |
Y3165964 |
Human PD-L1 inhibitor IV |
2135542-83-3 |
99% |
Y3293833 |
EMD527040 |
851333-14-7 |
99% |
Y3167817 |
EPI-589 |
1147883-03-1 |
99% |
Y3291324 |
Isobutyl-deoxynyboquinone |
1430798-22-3 |
99% |
Y3296888 |
PS372424 hydrochloride |
1596362-29-6 |
98% |
Y3160776 |
JC-171 |
2112809-98-8 |
98% |
Y3160529 |
CBP/p300-IN-10 |
2259641-71-7 |
98.69% |
Y3169560 |
PYBG-BODIPY |
2068027-79-0 |
98% |
Y3293147 |
Exatecan-d5 (mesylate) |
2819276-88-3 |
99% |
Y3308665 |
2-(6-(dimethylamino)-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetic acid |
2093306-64-8 |
95% |
Y3152235 |
(S)-5-(pyrrolidin-2-yl)-1H-pyrazole dihydrochloride |
2287246-69-7 |
83% |
Y3157466 |
(R)-5-(pyrrolidin-2-yl)-1H-pyrazole dihydrochloride |
2411180-15-7 |
95% |
Y3151376 |
3-Hydroxybenzene-1-sulfonyl fluoride |
1394917-55-5 |
95% |
Y3108353 |
5-Chloro-3-phenylpyrazolo[1,5-a]pyrimidine |
1956386-12-1 |
97% |
Y3108345 |
tert-Butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate |
1629585-65-4 |
95% |
Y3106364 |
4,4'-((2,2-Bis((4-aminophenoxy)methyl)propane-1,3-diyl)bis(oxy))dianiline |
60713-81-7 |
95% |
Y3106399 |
Methyl hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxylate |
1550654-99-3 |
95% |
Y3105255 |
N-(3-(2-Bromoacetyl)phenyl)methanesulfonamide |
2065-04-5 |
98% |
Y3103765 |
5-((R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-4'-methoxy-6'-((S)-2-methylpiperazin-1-yl)-[3,3'-bipyridin]-6-amine |
1621519-26-3 |
98% |
Y3103905 |
2,8-Bis(trifluoromethoxy)-5-(trifluoromethyl)-5H-dibenzo[b,d]thiophen-5-ium trifluoromethanesulfonate |
2833773-70-7 |
95% |
Y3103939 |
4-(1-Methylpiperidin-4-yl)benzoic acid hydrochloride |
354813-49-3 |
98% |